Injectable human recombinant collagen matrices limit adverse remodeling and improve cardiac function after myocardial infarction | Nature Communications
Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure | Journal of the American College of Cardiology
New genetic insights on common cause of heart attack in younger women – Harvard Gazette
Fibrosis in endstage human heart failure: Severe changes in collagen metabolism and MMP/TIMP profiles - International Journal of Cardiology
Cardiac fibrosis – A short review of causes and therapeutic strategies - ScienceDirect
Established and Emerging Roles of Biomarkers in Heart Failure | Circulation Research
Metabolites | Free Full-Text | Extracellular Matrix in Heart Disease: Focus on Circulating Collagen Type I and III Derived Peptides as Biomarkers of Myocardial Fibrosis and Their Potential in the Prognosis of
Type 5 Collagen May Determine Amount of Scarring after Heart Attack
Aging and the cardiac collagen matrix: Novel mediators of fibrotic remodelling - ScienceDirect
Cardiac inflammation in COVID-19: Lessons from heart failure - ScienceDirect
Friedreich's Ataxia Study Suggests Collagen as Heart Disease Biomarker
Collagen Biomarkers and Incidence of New Onset of Atrial Fibrillation in Subjects With No Overt Cardiovascular Disease at Baseline | Circulation: Arrhythmia and Electrophysiology
Collagen May Help To Prevent Cancer and Heart Disease
Mechanisms of cardiac collagen deposition in experimental models and human disease - Translational Research
Complex Relationship Between Cardiac Fibroblasts and Cardiomyocytes in Health and Disease | Journal of the American Heart Association
PLOS ONE: Long-Term Overexpression of Hsp70 Does Not Protect against Cardiac Dysfunction and Adverse Remodeling in a MURC Transgenic Mouse Model with Chronic Heart Failure and Atrial Fibrillation
Frontiers | Bearing My Heart: The Role of Extracellular Matrix on Cardiac Development, Homeostasis, and Injury Response | Cell and Developmental Biology